Wu S - Search Results

1

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.

Hong S, Zhang Y, Yu G, Peng P, Peng J, Jia J, Wu X, Huang Y, Yang Y, Lin Q, Xi X, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C, Fang W, Zhang L. Hong S, et al. Among authors: wu x, wu s. J Clin Oncol. 2021 Oct 10;39(29):3273-3282. doi: 10.1200/JCO.21.00396. Epub 2021 Aug 11. J Clin Oncol. 2021. PMID: 34379443 Free PMC article. Clinical Trial.

2

[Efficacy of combined paclitaxel and oxaliplatin therapy in patients with pretreated advanced non-small cell lung cancer].

Xie CY, Wu SX, Zhang P. Xie CY, et al. Ai Zheng. 2004 Aug;23(8):947-50. Ai Zheng. 2004. PMID: 15301721 Chinese.

3

[Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].

Jiang YY, Wu SX, Zhang P, Xie CY, Wang J, Sun CC. Jiang YY, et al. Zhonghua Yi Xue Za Zhi. 2008 Aug 12;88(31):2171-4. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080664 Chinese.

4

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.

Jing Z, Gong L, Xie CY, Zhang L, Su HF, Deng X, Wu SX. Jing Z, et al. Radiother Oncol. 2009 Dec;93(3):468-73. doi: 10.1016/j.radonc.2009.08.008. Epub 2009 Sep 8. Radiother Oncol. 2009. PMID: 19744737

5

Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.

Li G, Hu W, Wang J, Deng X, Zhang P, Zhang X, Xie C, Wu S. Li G, et al. Among authors: wu s. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1407-12. doi: 10.1016/j.ijrobp.2009.10.012. Epub 2010 Mar 28. Int J Radiat Oncol Biol Phys. 2010. PMID: 20350790 Clinical Trial.

6

The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.

Zhao L, Wan Q, Zhou Y, Deng X, Xie C, Wu S. Zhao L, et al. Among authors: wu s. Radiother Oncol. 2011 Jan;98(1):23-7. doi: 10.1016/j.radonc.2010.10.009. Epub 2010 Oct 30. Radiother Oncol. 2011. PMID: 21040992

7

Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma.

Peng Z, Xie C, Wan Q, Zhang L, Li W, Wu S. Peng Z, et al. Among authors: wu s. Mitochondrion. 2011 Mar;11(2):327-33. doi: 10.1016/j.mito.2010.12.008. Epub 2010 Dec 16. Mitochondrion. 2011. PMID: 21168531

8

[Phase II study of radiotherapy plus erlotinib for elder patients with esophageal carcinoma].

Zhang XB, Xie CY, Li WF, Zhang P, Wu SX. Zhang XB, et al. Zhonghua Yi Xue Za Zhi. 2012 Jun 19;92(23):1615-7. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22944130 Clinical Trial. Chinese.

9

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers.

Liu KJ, Guan ZZ, Liang Y, Yang XQ, Peng J, Huang H, Shao QX, Wang MZ, Zhu YZ, Wu CP, Wang SB, Xiong JP, Bai YX, Yu SY, Zhang Y, Hu XH, Feng JF, Wu SX, Jiao SC, Zhou CC, Wang J, Wu HY. Liu KJ, et al. Arch Med Sci. 2014 Aug 29;10(4):717-24. doi: 10.5114/aoms.2014.44862. Arch Med Sci. 2014. PMID: 25276156 Free PMC article.

10

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.

Wu S, Xia B, Han F, Xie R, Song T, Lu L, Yu W, Deng X, He Q, Zhao C, Xie C. Wu S, et al. PLoS One. 2015 Aug 6;10(8):e0134491. doi: 10.1371/journal.pone.0134491. eCollection 2015. PLoS One. 2015. PMID: 26248338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,380 results

Search Page

Filters